Ian Clements's most recent trade in Mirum Pharmaceuticals Inc was a trade of 325 Common Stock done at an average price of $17.1 . Disclosure was reported to the exchange on Nov. 10, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Mirum Pharmaceuticals Inc | Ian Clements | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 17.05 per share. | 10 Nov 2022 | 325 | 30,011 (0%) | 0% | 17.1 | 5,542 | Common Stock |
| Mirum Pharmaceuticals Inc | Ian Clements | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 13.57 per share. | 10 May 2022 | 1,125 | 29,686 (0%) | 0% | 13.6 | 15,262 | Common Stock |
| Mirum Pharmaceuticals Inc | Ian Clements | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2022 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Ian Clements | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2022 | 10,000 | 28,561 (0%) | 0% | 0 | Common Stock | |
| Mirum Pharmaceuticals Inc | Ian Clements | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 13.90 per share. | 24 Nov 2021 | 750 | 18,561 (0%) | 0% | 13.9 | 10,425 | Common Stock |
| Mirum Pharmaceuticals Inc | Ian Clements | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 14.40 per share. | 24 Nov 2021 | 700 | 17,811 (0%) | 0% | 14.4 | 10,080 | Common Stock |
| Mirum Pharmaceuticals Inc | Ian Clements | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 13.52 per share. | 10 Nov 2021 | 458 | 17,111 (0%) | 0% | 13.5 | 6,190 | Common Stock |
| Mirum Pharmaceuticals Inc | Ian Clements | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 14.62 per share. | 10 May 2021 | 981 | 8,852 (0%) | 0% | 14.6 | 14,342 | Common Stock |
| Mirum Pharmaceuticals Inc | Ian Clements | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 75,000 | 75,000 | - | - | Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Ian Clements | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 18.65 per share. | 23 Dec 2020 | 1,562 | 7,841 (0%) | 0% | 18.6 | 29,131 | Common Stock |
| Mirum Pharmaceuticals Inc | Ian Clements | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 18.55 per share. | 23 Dec 2020 | 908 | 6,279 (0%) | 0% | 18.5 | 16,843 | Common Stock |
| Mirum Pharmaceuticals Inc | Ian Clements | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 15.27 per share. | 10 Nov 2020 | 1,371 | 5,371 (0%) | 0% | 15.3 | 20,930 | Common Stock |